This week's coverage discusses the M&A report, $50B+ investments, automated cell therapy, vaccine approvals, and risks from the US leaving the WHO. In this PharmTech video feature, we highlight the ...

Vertical integration and securing scarce inputs are becoming strategic priorities due to complex biologics and fragile supply chains. M&A report claims that pharma is now targeting vertical ...

In a 2026 industry outlook interview, Raj Puri explains balancing speed with the financial and regulatory risks of accelerated drug launches via alignment. Raj Puri, chief commercial officer at ...

Eli Lilly will invest $3.5 billion in a Pennsylvania facility for injectable weight-loss medicines, creating 850 new jobs and starting by 2031.

Vetter's €1.5 billion investment focuses on expanding commercial and clinical production, with a new plant in Saarlouis, Germany, creating up to 2,000 jobs. The US expansion prioritizes clinical ...